Differential MHC class II presentation of a pathogenic autoantigen during health and disease

Journal of Immunology

Volumn 176, Issue 6, 2006, Pages 3438-3448

  Shih, Fei F ^a   Racz, Jennifer ^a   Allen, Paul M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUCOSE 6 PHOSPHATE ISOMERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; IMMUNE COMPLEX DISEASE; IMMUNOREACTIVITY; INFECTION; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 33644845965     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.6.3438     Document Type: Article

References (63)

1. Kouskoff, V., A.-S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811-822.
2. Basu, D., S. Horvath, I. Matsumoto, D. H. Fremont, and P. M. Allen. 2000. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. J. Immunol. 164: 5788-5796.
3. Matsumoto, I., M. Maccioni, D. M. Lee, M. Maurice, B. Simmons, M. Brenner, D. Mathis, and C. Benoist. 2002. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3: 360-365.
4. Mandik-Nayak, L., B. T. Wipke, F. F. Shih, E. R. Unanue, and P. M. Allen. 2002. Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc. Natl. Acad. Sci. USA 99: 14368-14373.
5. Chesnut, R. W., and H. M. Grey. 1981. Studies on the capacity of B cells to serve as antigen-presenting cells. J. Immunol. 126: 1075-1079.
6. Malnati, M. S., M. Marti, T. LaVaute, D. Jaraquemada, W. Biddison, R. DeMars, and E. O. Long. 1992. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 357: 702-704.
7. Jacobson, S., R. P. Sekaly, C. L. Jacobson, H. E. McFarland, and E. Long. 1989. HLA class II restricted presentation of cytoplasmic measles virus antigen to cytotoxic T cells. J. Virol. 63: 1756-1764.
8. Dani, A., A. Chaudhry, P. Mukherjee, D. Rajagopal, S. Bhatia, A. George, V. Bal, S. Rath, and S. Mayor. 2004. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J. Cell Sci. 117: 4219-4230.
9. Mukherjee, P., A. Dani, S. Bhatia, N. Singh, A. Y. Rudensky, A. George, V. Bal, S. Mayor, and S. Rath. 2001. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis. J. Immunol. 167: 2632-2641.
10. Tewari, M. K., G. Sinnathamby, D. Rajagopal, and L. C. Eisenlohr. 2005. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6: 287-294.
11. Dongre, A. R., S. Kovats, P. deRoos, A. L. McCormack, T. Nakagawa, V. Paharkova-Vatchkova, J. Eng, H. Caldwell, J. R. Yates III, and A. Y. Rudensky. 2001. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31: 1485-1494.
12. g7 molecule are unique and determined by the amino acid changes in the P9 pocket. J. Immunol. 168: 1235-1243.
13. Niinaka, Y., S. Paku, A. Haga, H. Watanabe, and A. Raz. 1998. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res. 58: 2667-2674.
14. Seve, P., T. Ferry, M. Koenig, P. Cathjebras, H. Rousset, and C. Broussolle. 2004. Lupus-like presentation of parvovirus B19 infection. Semin. Arthritis Rheum. 34: 642-648.
15. Musaji, A., M. Meite, L. Detalle, S. Franquin, F. Cormont, V. Preat, S. Izui, and J. P. Coutelier. 2005. Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia. Autoimmun. Rev. 4: 247-252.
16. Ramos, O. P., E. E. Silva, D. P. Falcao, and B. M. de Medeiros. 2005. Production of autoantibodies associated with polyclonal activation in Yersinia enterocolitica O: 8-infected mice. Microbiol. Immunol. 49: 129-137.
17. Bogdanos, D. P., G. Mieli-Vergani, and D. Vergani. 2005. Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? Clin. Infect. Dis. 40: 508-510.
18. Asherson, R. A., and R. Cervera. 2003. Antiphospholipid antibodies and infections. Ann. Rheum. Dis. 62: 388-393.
19. Blutt, S. E., S. E. Crawford, K. L. Warfield, D. E. Lewis, M. K. Estes, and M. E. Conner. 2004. The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J. Virol. 78: 6974-6981.
20. + T regulatory cells. J. Exp. Med. 199: 323-335.
21. Sloan-Lancaster, J., and P. M. Allen. 1997. Antigen processing and presentation to T cells. In Weir's Handbook of Experimental Immunology. L. A. Herzenberg, D. M. Weir, and C. Blackwell, eds. Blackwell Scientific, Oxford, pp. 119.111-119.119.
22. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
23. Nikolic, T., M. Bunk, H. A. Drexhage, and P. J. Leenen. 2004. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro. J. Immunol. 173: 4342-4351.
24. Prasad, S. J., and C. C. Goodnow. 2002. Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. Int. Immunol. 14: 677-684.
25. Vasquez, A. C., M. Feili-Hariri, R. J. Tan, and P. A. Morel. 2004. Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice. Clin. Exp. Immunol. 135: 209-218.
26. Morel, P. A., A. C. Vasquez, and M. Feili-Hariri. 1999. Immunobiology of DC in NOD mice. J. Leukocyte Biol. 66: 276-280.
27. Dahlen, E., G. Hedlund, and K. Dawe. 2000. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J. Immunol. 164: 2444-2456.
28. Wilson, N. S., D. El-Sukkari, and J. A. Villadangos. 2004. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103: 2187-2195.
29. Veeraswamy, R. K., M. Cella, M. Colonna, and E. R. Unanue. 2003. Dendritic cells process and present antigens across a range of maturation states. J. Immunol. 170: 5367-5372.
30. Matsumoto, I., A. Staub, C. Benoist, and D. Mathis. 1999. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286: 1732-1735.
31. Liu, Y.-J., H. Kanzler, V. Soumelis, and M. Gilliet. 2001. Dendritic cell lineage, plasticity, and cross-regulation. Nat. Immunol. 2: 585-589.
32. Wilson, N. S., D. El-Sukkari, G. T. Belz, C. M. Smith, R. J. Steptoe, W. R. Heath, K. Shortman, and J. A. Villadangos. 2003. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102: 2187-2194.
33. Ardavin, C., and K. Shortman. 1992. Cell surface marker analysis of mouse thymic dendritic cells. Eur. J. Immunol. 22: 859-862.
34. Lopes-Carvalho, T., and J. F. Kearney. 2004. Development and selection of marginal zone B cells. Immunol. Rev. 197: 192-205.
35. Attanavanich, K., and J. F. Kearney. 2004. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172: 803-811.
36. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcgR11-deficient mice. Nature 379: 346-349.
37. Clynes, R., J. S. Maizes, R. Guinamard, M. Ono, T. Takai, and J. V. Ravetch. 1999. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189: 179-185.
38. Fukuyama, H., F. Nimmerjahn, and J. V. Ravetch. 2005. The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat. Immunol. 6: 99-106.
39. Moll, T., L. Nitschke, M. Carroll, J. V. Ravetch, and S. Izui. 2004. A critical role for Fcγ RIIB in the induction of rheumatoid factors. J. Immunol. 173: 4724-4728.
40. Ravetch, J. V., and R. A. Clynes. 1998. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16: 421-432.
41. Waldner, H., M. Collins, and V. K. Kuchroo. 2004. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest 113: 990-997.
42. Singh, V. K., K. Yamaki, T. Abe, and T. Shinohara. 1989. Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: induction of experimental autoimmune uveitis and lymphocyte cross-reaction. Cell Immunol. 122: 262-273.
43. 1 B cells. J. Immunol. 143: 2202-2208.
44. Rose, N. R. 1989. Pathogenic mechanisms in autoimmune diseases. Clin. Immunol. Immunopathol. 53(Suppl.): S7-S16.
45. Benoist, C., and D. Mathis. 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2: 797-801.
46. Medzhitov, R., and C. A. Janeway, Jr. 2000. How does the immune system distinguish self from nonself? Semin. Immunol. 12: 185-188.
47. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
48. + T cells. J. Immunol 165: 4870-4876.
49. + T cell tolerance to peripherally expressed antigens. J. Immunol. 163: 723-727.
50. Zhou, D., P. Li, Y. Lin, J. M. Lott, A. D. Hislop, D. H. Canaday, R. R. Brutkiewicz, and J. S. Slum. 2005. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 22: 571-581.
51. Lich, J. D., J. F. Elliott, and J. S. Blum. 2000. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J. Exp. Med. 191: 1513-1524.
52. Yan, G., Y. Fu, and D. L. Faustman. 1997. Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. J. Immunol. 159: 3068-3080.
53. Hayashi, T., and D. Faustman. 1999. NOD mice are defective in proteasome production and activation of NF-κB. Mol. Cell. Biol 19: 8646-8659.
54. Boudaly, S., J. Morin, R. Berthier, P. Marche, and C. Boitard. 2002. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice. Eur. Cytokine Network 13: 29-37.
55. Steptoe, R. J., J. M. Ritchie, and L. C. Harrison. 2002. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. J. Immunol. 168: 5032-5041.
56. Poligone, B., D. J. Weaver, Jr., P. Sen, A. S. Baldwin, Jr., and R, Tisch. 2002. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168: 188-196.
57. Wheat, W., R. Kupfer, D. G. Gutches, G. R. Rayat, J. Beilke, R. I. Scheinman, and D. R. Wegmann. 2004. Increased NF-κB activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur. J. Immunol. 34: 1395-1404.
58. Alfonso, C., and L. Karlsson. 2000. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18: 113-142.
59. Alfonso, C., G. S. Williams, J. O. Han, J. A. Westberg, O. Winqvist, and L. Karlsson. 2003. Analysis of H2-O influence on antigen presentation by B cells. J. Immunol. 171: 2331-2337.
60. Fallas, J. L., H. M. Tobin, O. Lou, D. Guo, D. B. Sant'Angelo, and L. K. Denzin. 2004. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J. Immunol. 173: 1549-1560.
61. Boes, M., A. Cuvillier, and H. Ploegh. 2004. Membrane specializations and endosome maturation in dendritic cells and B cells. Trends Cell Biol. 14: 175-183.
62. Sproul, T. W., P. C. Cheng, M. L. Dykstra, and S. K. Pierce. 2000. A role for MHC class II antigen processing in B cell development. Int. Rev. Immunol. 19: 139-155.
63. Lankar, D., H. Vincent-Schneider, V. Briken, T. Yokozeki, G. Raposo, and C. Bonnerot. 2002. Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation. J. Exp. Med. 195: 461-472.